Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03531502 · ClinicalTrials.gov registry record · NA
Initial Management of Patients Receiving a Single Shock (IMPRESS)
A NA study, sponsored by Saint Luke's Health System.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03531502 is a NA study that was terminated before completion, run by Saint Luke's Health System. The registered enrollment target is 30 participants.
The verdict
NCT03531502, a NA study, was terminated before completion, sponsored by Saint Luke's Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to determine the optimal treatment for patients who receive a single shock from their implantable cardioverter defibrillator (ICD). All participants in this study will be fitted with a special electrode vest to detect the origin of heart rhythm abnormalities and then they will undergo a procedure called Non-Invasive Programmed Stimulation (NIPS). This procedure involves sedating a participants with anesthesia and then using the participant's own ICD to try to stimulate the heart to go into ventricular tachycardia. If this procedure is unable to induce the participant into ventricular tachycardia, then the participant will just be managed with usual care and will not be placed on any additional medications and will not undergo an ablation. However, if the NIPS induces the ventricular tachycardia, the electrode vest will be used to determine the origin of the abnormal heart rhythm inside the heart. After a successful NIPS procedure, the participants will be randomly assigned to either be placed on medication therapy or undergo catheter ablation. The outcomes from all three groups will be compared and the researchers hope to better understand which participants are most likely to benefit from watchful waiting versus medication versus catheter ablation.
Interventions
- PROCEDURE Ventricular Tachycardia Ablation
- OTHER Standard Medical Therapy
- PROCEDURE Non-Invasive Programmed Stimulation (NIPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2023-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03531502
The ClinicalTrials.gov registry entry for NCT03531502 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ventricular Tachycardia Ablation is the first listed.
NCT03531502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03531502 about?
NCT03531502 is a clinical study titled "Initial Management of Patients Receiving a Single Shock (IMPRESS)". The goal of this study is to determine the optimal treatment for patients who receive a single shock from their implantable cardioverter defibrillator (ICD). All participants in this study will be fitted with a special electrode vest to detect the origin of heart rhythm abnormalities and then they w...
What is the current status of trial NCT03531502?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2018-04-09. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT03531502?
The interventions under investigation include: Ventricular Tachycardia Ablation (PROCEDURE), Standard Medical Therapy (OTHER), Non-Invasive Programmed Stimulation (NIPS) (PROCEDURE).
Who is sponsoring clinical trial NCT03531502?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.